Lipid management in contemporary community practice: Results from the Provider Assessment of Lipid Management (PALM) Registry-Reference-Cited by-同舟云学术

Lipid management in contemporary community practice: Results from the Provider Assessment of Lipid Management (PALM) Registry

Published:2017-11 Issue: Volume:193 Page:84-92
ISSN:0002-8703
Container-title:American Heart Journal
language:en
Short-container-title:American Heart Journal

Author:

Navar Ann Marie,Wang Tracy Y.,Li Shuang,Robinson Jennifer G.,Goldberg Anne C.,Virani Salim,Roger Veronique L.,Wilson Peter W.F.,Elassal Joseph,Lee L. Veronica,Peterson Eric D.

Funder

Sanofi Pharmaceuticals

Regeneron Pharmaceuticals

National Heart, Lung, and Blood Institute

National Institutes of Health

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference14 articles.

1. 2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines;Stone;Circulation,2014

2. Third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report;National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III);Circulation,2002

3. Rosuvastatin to prevent vascular events in men and women with elevated c-reactive protein;Ridker;N Engl J Med,2008

4. Intensive versus moderate lipid lowering with statins after acute coronary syndromes;Cannon;N Engl J Med,2004

5. Intensive lipid lowering with atorvastatin in patients with stable coronary disease;LaRosa;N Engl J Med,2005

Cited by 64 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Closing the gap between guidelines and clinical practice for managing dyslipidemia: where are we now?;Expert Review of Cardiovascular Therapy;2024-09

2. Physician preferences for treatment of low-density lipoprotein cholesterol among patients with atherosclerotic cardiovascular disease (ASCVD)–A discrete choice experiment;Heliyon;2024-08

3. Achievement of LDL-C <55 mg/dL among US adults: Findings from the cvMOBIUS2 registry;American Heart Journal;2024-07

4. Two randomized controlled trials of nudges to encourage referrals to centralized pharmacy services for evidence-based statin initiation in high-risk patients: Rationale and design of the SUPER LIPID program;American Heart Journal;2024-07

5. Sex-based utilization of guideline recommended statin therapy and cardiovascular disease outcomes: Data from a multisite healthcare network primary prevention cohort;American Journal of Preventive Cardiology;2024-06